Publications by authors named "Muhammad Arba"

Claim this Profile
E
Exploring the antidiabetic potential of Sulawesi ethnomedicines: A study of and in a model of hyperglycemia.
Firzan Nainu, Muhammad A Bahar, Habibie Habibie, Ahmad Najib, Muhammad S Zubair, Muhammad Arba

Narra J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the binding mechanism of the active form of Remdesivir to RdRp of SARS-CoV-2 and designing new potential analogues: Insights from molecular dynamics simulations.
Muhammad Arba, Nicholas Paradis, Setyanto T Wahyudi, Dylan J Brunt, Katherine R Hausman

Chem Phys Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Search for Cyclooxygenase-2 (COX-2) Inhibitors for the Treatment of Inflammation Disease: An in-silico Study.
Ruslin Ruslin, Yamin Yamin, Henny Kasmawati, Samuel Mangrura, Laode Kadidae, Muhammad Arba

J Multidiscip Healthc· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel inhibitors to ADP ribose phosphatase of SARS-CoV-2 identified by structure-based high throughput virtual screening and molecular dynamics simulations.
Dhrumi C Patel, Katherine R Hausman, Muhammad Arba, Annie Tran, Phillip M Lakernick

Comput Biol Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-Like Protease Inhibitors from Roscoe.
Muhammad Sulaiman Zubair, Saipul Maulana, Agustinus Widodo, Ramadanil Pitopang, Muhammad Arba

Molecules· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2.
Muhammad Arba, Setyanto Tri Wahyudi, Dylan J Brunt, Nicholas Paradis, Chun Wu

Comput Biol Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore-based virtual screening for identifying β5 subunit inhibitor of 20S proteasome.
Muhammad Arba, Andry Nur-Hidayat, Slamet Ibrahim Surantaadmaja, Daryono H Tjahjono

Comput Biol Chem· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome.
Muhammad Arba, Andry Nur-Hidayat, Ruslin, Muhammad Yusuf, Sumarlin

Comput Biol Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular modeling of cationic porphyrin-anthraquinone hybrids as DNA topoisomerase IIβ inhibitors.
Muhammad Arba, Ruslin, Sunandar Ihsan, Setyanto Tri Wahyudi, Daryono H Tjahjono

Comput Biol Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico study of porphyrin-anthraquinone hybrids as CDK2 inhibitor.
Muhammad Arba, Sunandar Ihsan, La Ode Ahmad Nur Ramadhan, Daryono Hadi Tjahjono

Comput Biol Chem· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular docking and dynamics simulations on the interaction of cationic porphyrin-anthraquinone hybrids with DNA G-quadruplexes.
Muhammad Arba, Rahmana E Kartasasmita, Daryono H Tjahjono

J Biomol Struct Dyn· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The binding modes of cationic porphyrin-anthraquinone hybrids to DNA duplexes: in silico study.
Muhammad Arba, Daryono H Tjahjono

J Biomol Struct Dyn· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis